Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
MOTION for Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled by Amgen Inc..(Gottfried, Michael)
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Page 1 of 4
UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ) AMGEN INC., ) ) Plaintiff, ) ) v. ) ) ) F. HOFFMANN-LA ROCHE ) LTD., a Swiss Company, ROCHE ) DIAGNOSTICS GmbH, a German ) Company and HOFFMANN-LA ROCHE ) INC., a New Jersey Corporation, ) ) Defendants. ) __________________________________________)
Civil Action No.: 05-12237 WGY
AMGEN INC.'S MOTION FOR SUMMARY JUDGMENT THAT DR. LIN'S ASSERTED CLAIMS ARE DEFINITE, ADEQUATELY DESCRIBED AND ENABLED For the reasons set forth in its supporting Memorandum, filed herewith, Plaintiff Amgen Inc. ("Amgen") respectfully submits this motion for summary judgment of Validity as to Definiteness, Written Description and Enablement. In particular, Amgen respectfully requests that the Court grant summary judgment in Amgen's favor that:
Dr. Lin's claims to the "non-naturally occurring" glycoprotein products set forth in Claims 3, 7-9, 11-12, and 14 of U.S. Patent No. 5,547,933 are definite because one of ordinary skill in the art could readily distinguish between EPO products that naturally occur in nature and those that are produced only though human
Page 2 of 4
intervention. (2) Dr. Lin's claim to a process for producing erythropoietin using cells that are "capable upon growth in culture of producing erythropoietin in the medium of their growth in excess of 100 U of erythropoietin per 106 cells in 48 hours, as determined by radioimmunoassay," as set forth at claim 7 of U.S. Patent No. 5,756,349, is definite because an ordinarily skilled artisan would understand this term to require: (a) The use of cells that produce in excess of 100 U of erythropoietin per 106 cells in 48 hours; and A radioimmunoassay results in which one type of antibody and EPO sample are calibrated against a known EPO standard.
Dr. Lin's asserted claims that refer to "human erythropoietin," as that term appears in the various asserted claims of U.S. Patent Nos. 5,547,933; 5,955,422; 5,756,349; 5,441,868; and 5,618,698 are definite because an ordinarily skilled artisan would understand this term to refer to all of the allelic variants of the human erythropoietin amino acid sequence, including EPO products that are produced according to Example 10 of Dr. Lin's patents. Dr. Lin's claims are described and enabled, because as a matter of law, Dr. Lin must enable one of ordinary skill in the art the full scope of his claimed invention, not how to make pegylated erythropoietin.
Request for Oral Argument Amgen respectfully requests that the Court hear oral argument regarding this motion.
Dated: June 20, 2007
Respectfully Submitted, AMGEN INC., By its attorneys,
/s/ Michael R. Gottfried D. DENNIS ALLEGRETTI (BBO#545511) -2-
Page 3 of 4
STUART L. WATT WENDY A. WHITEFORD MONIQUE L. CORDRAY DARRELL G. DOTSON KIMBERLIN L. MORLEY ERICA S. OLSON AMGEN INC. One Amgen Center Drive Thousand Oaks, CA 91320-1789 (805) 447-5000
MICHAEL R. GOTTFRIED (BBO# 542156) PATRICIA R. RICH (BBO# 640578) DUANE MORRIS LLP 470 Atlantic Avenue, Suite 500 Boston, MA 02210 Telephone: (857) 488-9200 Facsimile: (857) 488-4201 LLOYD R. DAY, JR. (pro hac vice) DAY CASEBEER MADRID & BATCHELDER LLP 20300 Stevens Creek Boulevard, Suite 400 Cupertino, CA 95014 Telephone: (408) 873-0110 Facsimile: (408) 873-0220 WILLIAM GAEDE III (pro hac vice) McDERMOTT WILL & EMERY 3150 Porter Drive Palo Alto, CA 94304 Telephone: (650) 813-5000 Facsimile: (650) 813-5100 KEVIN M. FLOWERS (pro hac vice) MARSHALL, GERSTEIN & BORUN LLP 233 South Wacker Drive 6300 Sears Tower Chicago, IL 60606 Telephone: (312) 474-6300 Facsimile: (312) 474-0448
Page 4 of 4
CERTIFICATE PURSUANT TO LOCAL RULE 7.1 I certify that counsel for the parties have conferred in an attempt to resolve or narrow the issues presented by this motion and no agreement was reached. /s/ Michael R. Gottfried Michael R. Gottfried
CERTIFICATE OF SERVICE I hereby certify that this document, filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of electronic filing and paper copies will be sent to those indicated as non-registered participants. /s/ Michael R. Gottfried Michael R. Gottfried
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?